Amesite Announces Equity Offerings to Strengthen Nasdaq Compliance

Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Amesite ( (AMST) ) has shared an update. On April 27, 2026, Amesite Inc. entered into agreements with institutional investors for a registered direct offering of 696,866 common shares at $1.435 each, alongside a concurrent private placement of an equal number of shares or pre-funded warrants plus Series A-1 and A-2 warrants. The company also struck an engagement with H.C. Wainwright & Co. as exclusive placement agent, compensating it with cash fees, management fees and warrants equal to 7% of the shares sold in the registered direct and private offerings. In parallel on April 27, 2026, Amesite agreed to sell pre-funded warrants and common warrants to institutional investors and, in an insider-led private placement, 418,118 common shares plus matching Series A-1 and A-2 warrants to certain officers and directors at $1.435 per share and accompanying warrants. The offerings, expected to close on April 28, 2026, are projected to raise about $2 million in gross proceeds from the registered direct and private placement, plus $600,000 from the insider-led tranche, bolstering working capital and potentially lifting stockholders’ equity above Nasdaq’s $2.5 million minimum, though the company remains subject to continued Nasdaq monitoring and possible future delisting risk. More about Amesite Amesite Inc., listed on Nasdaq as AMST, is an AI-driven software company that develops technology platform solutions for healthcare. Its flagship product, NurseMagic™, is an AI-native assistant and enterprise platform, including an EMR for non-acute care, used by more than 130 professions across all 50 U.S. states and over 20 countries for clinical documentation, decision support and workflow integration. Built on proprietary AI and designed to meet applicable regulatory and security requirements, NurseMagic™ serves both business and consumer users. The platform offers multilingual support and operational insights, positioning Amesite in the growing market for AI-enabled clinical and operational tools in healthcare. Average Trading Volume: 243,440 Technical Sentiment Signal: Sell Current Market Cap: $7.22M For a thorough assessment of AMST stock, go to TipRanks’ Stock Analysis page.